Atazanavir and Endothelial Function in Older HIV Patients
Status:
Completed
Trial end date:
2016-06-01
Target enrollment:
Participant gender:
Summary
The investigators hypothesize that older subjects with HIV randomly assigned to atazanavir
will have increased bilirubin levels, reduced oxidative stress, and improved flow-mediated,
endothelium-dependent vasodilation compared to subjects not switched to atazanavir.